SILVAKLENZ

LIVE

Serial Number

87324050

Owner

Molecular Therapeutics

Attorney

Matthew T. Hoots

First Use Date

Aug 8, 2005

Filing Date

Feb 3, 2017

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

SILVAKLENZ Trademark

Serial Number: 87324050 • Registration: 5295081

SILVAKLENZ is a trademark filed by Molecular Therapeutics on February 3, 2017. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

Molecular Therapeutics (9 trademarks)

425 River Rd, Suite 422
Athens, GA 30602

Entity Type: 13

Legal Representation

Attorney of Record

Matthew T. Hoots

804 trademarks filed View all →

Trademark Details

Filing Date

February 3, 2017

Registration Date

September 26, 2017

First Use Anywhere

August 8, 2005

First Use in Commerce

August 8, 2005

Published for Opposition

July 11, 2017

Goods & Services

Medical cleansers for skin and wounds featuring silver as an ingredient

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Mar 11, 2024 NA85

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

Mar 11, 2024 C15A

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Mar 11, 2024 APRE

TEAS SECTION 8 & 15 RECEIVED

Sep 18, 2023 E815

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Sep 26, 2022 REM1

REGISTERED-PRINCIPAL REGISTER

Sep 26, 2017 R.PR

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jul 11, 2017 NPUB

PUBLISHED FOR OPPOSITION

Jul 11, 2017 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jun 21, 2017 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

May 27, 2017 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

May 26, 2017 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

May 25, 2017 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

May 25, 2017 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

May 9, 2017 GNRN

NON-FINAL ACTION E-MAILED

May 9, 2017 GNRT

NON-FINAL ACTION WRITTEN

May 9, 2017 CNRT

ASSIGNED TO EXAMINER

Apr 28, 2017 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Feb 8, 2017 NWOS

NEW APPLICATION ENTERED

Feb 7, 2017 NWAP

Related Trademarks

More from this Owner

MOLECULAR THERAPEUTICS

NEOCIDE-3

More in Same Class

BERRY CLUB